ANALYSIS OF SERINE PROTEASE INHIBITOR KAZAL TYPE 1 (SPINK1) IN PROSTATE CANCER IN AFRICAN-AMERICAN MEN

$78,505FY2011Department of DefenseDOD

Howard University, Washington DC

Investigators